{
    "id": 32444,
    "fullName": "KDM1A over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "KDM1A over exp indicates an over expression of the Kdm1a protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 23028,
        "geneSymbol": "KDM1A",
        "terms": [
            "KDM1A",
            "AOF2",
            "BHC110",
            "CPRF",
            "KDM1",
            "LSD1"
        ]
    },
    "variant": "over exp",
    "createDate": "02/06/2020",
    "updateDate": "02/06/2020",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20255,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, SP-2509 treatment inhibited viability of Ewing sarcoma cell lines overexpressing KDM1A, and harboring EWSR1 fusions in culture (PMID: 29997151).",
            "molecularProfile": {
                "id": 34977,
                "profileName": "KDM1A over exp"
            },
            "therapy": {
                "id": 9301,
                "therapyName": "SP-2509",
                "synonyms": null
            },
            "indication": {
                "id": 3369,
                "name": "Ewing sarcoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17780,
                    "pubMedId": 29997151,
                    "title": "Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29997151"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20254,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Ewing sarcoma cell lines overexpressing KDM1A and harboring EWSR1 fusions demonstrated resistance to GSK-LSD1 treatment in culture (PMID: 29997151).",
            "molecularProfile": {
                "id": 34977,
                "profileName": "KDM1A over exp"
            },
            "therapy": {
                "id": 9300,
                "therapyName": "GSK-LSD1",
                "synonyms": null
            },
            "indication": {
                "id": 3369,
                "name": "Ewing sarcoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 17780,
                    "pubMedId": 29997151,
                    "title": "Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29997151"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20256,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Ewing sarcoma cell lines overexpressing KDM1A and harboring EWSR1-FLI1 fusions demonstrated resistance to Parnate (tranylcypromine) treatment in culture (PMID: 29997151).",
            "molecularProfile": {
                "id": 34977,
                "profileName": "KDM1A over exp"
            },
            "therapy": {
                "id": 8202,
                "therapyName": "Tranylcypromine",
                "synonyms": null
            },
            "indication": {
                "id": 3369,
                "name": "Ewing sarcoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 17780,
                    "pubMedId": 29997151,
                    "title": "Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29997151"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34977,
            "profileName": "KDM1A over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 34978,
            "profileName": "EWSR1 - FLI1 KDM1A over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 34979,
            "profileName": "EWSR1 - ERG KDM1A over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}